Publicação
Loop diuretic discontinuation in chronic heart failure patients: A retrospective study
| dc.contributor.author | Silva, G | |
| dc.contributor.author | Moura, B | |
| dc.contributor.author | Moreira, E | |
| dc.contributor.author | Camila Dias, C | |
| dc.contributor.author | Sousa Pinto, B | |
| dc.contributor.author | Campelo, M | |
| dc.contributor.author | Amorim, S | |
| dc.contributor.author | Martins, E | |
| dc.contributor.author | Pinto, R | |
| dc.contributor.author | Maia Araújo, P | |
| dc.contributor.author | Resende, CX | |
| dc.contributor.author | Mena, B | |
| dc.contributor.author | Grácio, T | |
| dc.contributor.author | Teixeira, A | |
| dc.contributor.author | Silva Cardoso, J | |
| dc.date.accessioned | 2024-08-22T22:30:24Z | |
| dc.date.available | 2024-08-22T22:30:24Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Introduction and objectives: The use of loop diuretics is central in managing congestion in heart failure (HF), but their impact on prognosis remains unclear. In euvolemic patients, dose reduction is recommended, but there is no recommendation on their discontinuation. This study aims to assess the impact of loop diuretic discontinuation on the prognosis of outpatients with HF with reduced ejection fraction. Methods: This retrospective cohort study collected data from medical records of patients followed in an outpatient HF clinic at a university hospital center. Patients were included if they had been on loop diuretics and these were discontinued. Demographic, clinical and laboratory data were collected, and number and type of congestive events during the one-year period after discontinuation were recorded. Results: Among 265 patients on loop diuretics, almost half (129) discontinued them at some point. Patients had optimized medical therapy, low median age, low New York Heart Association class, low B-type natriuretic peptide values, normal blood pressure, controlled heart rate and kidney function within normal limits. Among 122 patients with one year of follow-up, 18 (14.8%) had a congestive event. Fifteen events (83.3%) were low-dose diuretic reinitiation at a scheduled visit. There were only three worsening heart failure events (2.5%) during the one-year period. A significant improvement in kidney function from discontinuation to the one-year follow-up appointment was also observed. Conclusions: In our cohort, loop diuretic discontinuation was possible and safe in a large proportion of patients. The results should be interpreted with caution and cannot be extrapolated to a broader population of HF patients. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Rev Port Cardiol. 2024 Jun 19:S0870-2551(24)00184-7. | pt_PT |
| dc.identifier.doi | 10.1016/j.repc.2024.02.012 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.26/51845 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.subject | Diuréticos | pt_PT |
| dc.subject | Insuficiência Cardíaca | pt_PT |
| dc.subject | Diuretics | pt_PT |
| dc.subject | Heart Failure | pt_PT |
| dc.title | Loop diuretic discontinuation in chronic heart failure patients: A retrospective study | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.title | Revista Portuguesa de Cardiologia | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |